Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011

Journal of Korean Medical Science

Volumn 28, Issue 1, 2013, Pages 67-73

  Lee, Sun Hee ^a   Kim, Kye Hyung ^a   Lee, Seung Geun ^a   Chen, Dong Hwan ^b   Jung, Dong Sik ^c   Moon, Chi Sook ^d   Park, Ji Young ^e   Chung, Joo Seop ^a   Kwak, Ihm Soo ^a   Cho, Goon Jae ^a  

^a Pusan National University Hospital   (South Korea)

^b Namgu Public Health Center   (South Korea)

^c Dong A University College of Medicine   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Kosin University College of Medicine   (South Korea)

Author keywords

Antiretroviral therapy; Cause of Death; HIV; Mortality

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; CAUSE OF DEATH; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; SOUTH KOREA;

ANTIRETROVIRAL THERAPY; CAUSE OF DEATH; HIV; MORTALITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84874789204     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.1.67     Document Type: Article

References (30)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD. Decline in the AIDS and death rates in the EUROSIDA study: an observational study. Lancet 2003; 362: 22-9.
2. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EUROSIDA study group. Lancet 1998; 352: 1725-30.
3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-60.
4. Aldaz P, Moreno-Iribas C, Egues N, Irisarri F, Floristan Y, Sola-Boneta J, Martinez-Artola V, Sagredo M, Castilla J. Mortality by causes in HIVinfected adults: comparison with the general population. BMC Public Health 2011; 11: 300.
5. Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, Furrer HJ, Telenti A, Battegay M, Flepp M, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362: 877-8.
6. Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, Rickenbach M. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 2004; 18: 1835-43.
7. Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007; 46: 72-7.
8. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, Vaeth M, Obel N. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146: 87-95.
9. Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Sorensen HT, Gerstoft J. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on haart: A population-based nationwide cohort study. PLoS One 2011; 6: e22698.
10. Marin B, Thiebaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, Hamouda O, Prins M, Walker S, Porter K, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS 2009; 23: 1743-53.
11. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New york city. Ann Intern Med 2006; 145: 397-406.
12. Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, Monforte A, Kirk O, Friis-Moller N, Phillips A, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS 2010; 24: 1537-48.
13. Korea Centers for Disease Control and Prevention. KCDC Public Health Weekly Report. Available at: http://www.cdc.go.kr/phwr [accessed on 1 June 2012].
14. Kee MK, Lee JH, Kim EJ, Lee J, Nam JG, Yoo BH, Kim SS. Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis 2009; 9: 128.
15. Choe PG, Park WB, Song JS, Kim NH, Park JY, Song KH, Park SW, Kim HB, Kim NJ, Oh MD. Late presentation of HIV disease and its associated factors among newly diagnosed patients before and after abolition of a government policy of mass mandatory screening. J Infect 2011; 63: 60-5.
16. Department of Health and Human Services. Archived Adult and Adolescent Guidelines. http://www.aidsinfo.hih.gov/guidelines/archive/adult-and-adolescent-gudilinens/[accessed on 1 June 2012]
17. International AIDS Society - USA. Guidelines archive. Available at: http://www.iasusa.org/guidelines-archive[accessed on 1 June 2012].
18. Department of Health and Human Services. Archived Opportunistic Infection Guidelines. http://www.aidsinfo.hih.gov/guidelines/archive/Opportunistic-infection-guidelines/ [accessed on 1 June 2012].
19. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19.
20. Dupon M, Texier-Maugein J, Leroy V, Sentilhes A, Pellegrin JL, Morlat P, Ragnaud JM, Chene G, Dabis F. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. Groupe d'epidemiologie clinique du sida en aquitaine. AIDS 1995; 9: 577-83.
21. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M, Avalos A, Friedman H, Dickinson D, Frank I, et al. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One 2008;3: e1725.
22. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006; 41: 194-200.
23. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE. Changes in mortality related to human immunodeficiency virus infection: Comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis 2003; 36: 1030-8.
24. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6: 99-106.
25. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV Outpatient Study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
26. Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, Prins M. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006; 20: 741-9.
27. Lundberg BE, Davidson AJ, Burman WJ. Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure. AIDS 2000; 14: 2559-66.
28. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996; 124: 633-42.
29. Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000; 162: 64-7.
30. Wolff AJ, O'Donnell AE. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001; 120: 1888-93.